Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium
Abstract: Streptococcus pneumoniae causes a high disease burden including pneumonia, meningitis and septicemia. Both a polysaccharide vaccine targeting 23serotypes (PPV23) and a 13-valent conjugate vaccine (PCV13) are indicated for persons aged over 50years. We developed and parameterized a static multi-cohort model to estimate the incremental cost-effectiveness and budget-impact of these vaccines at different uptake levels. Using three different vaccine efficacy scenarios regarding non-invasive pneumococcal pneumonia and extensive uni- and multivariate sensitivity analyses, we found a strong... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2018 |
Schlagwörter: | Biology / Human medicine / Engineering sciences. Technology |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26599791 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/10067/1521140151162165141 |